Ambry Genetics is a recognized leader in comprehensive clinical genetic testing. Ambry Genetics has created a new division to support pharmaceutical research, Clinical Research Organizations (CROs) and clinical trials.

The role of genetics in drug development and clinical trials is expanding as new technologies enable rapid analysis of genetic causes of drug response and toxicity. An individual’s genetic make-up can have a significant impact on how they respond to certain drugs. Ambry Genetics’ new services provide genetic testing and bio-informatics to researchers.

Ambry Genetics has the capabilities to perform SNP analysis, custom mutation panels, drug metabolism panels, full gene sequencing, genome sequencing and gene expression analysis. Testing can be performed at all levels of regulatory compliance from basic research, GLP compliant to clinical testing in our CLIA licensed and CAP accredited laboratory.